EFFECT OF COMPLEMENT FACTOR 5A RECEPTOR 1 (C5AR1) ANTAGONIST ACT-1014-6,470 ON THE CYTOCHROME P450 2C19 AND 3A4 SUBSTRATES OMEPRAZOLE AND MIDAZOLAM IN A COCKTAIL STUDY IN HEALTHY SUBJECTS

被引：0
|
作者：
Anliker-Ort, S. M. [1 ,2 ]
Berger, B. [1 ]
Kaufmann, P. [1 ]
Jana, L. [3 ]
van den Anker, J. [4 ]
Dingemanse, J. [1 ]
机构：
[1] Idorsia Pharmaceut, Allschwil, Switzerland
[2] Univ Childrens Hosp, Basel, Switzerland
[3] CEPHA Sro, Plzen, Czech Republic
[4] Univ Basel Childrens Hosp, Basel, Switzerland
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-054
引用
收藏
页码：S61 / S62
页数：2
相关论文
共 32 条
  • [31] Effects of cytochrome P450 (CYP3A4 and CYP2C19) inhibition and induction on the exposure of selumetinib, a MEK1/2 inhibitor, in healthy subjects: results from two clinical trials
    Angela W. Dymond
    Karen So
    Paul Martin
    Yifan Huang
    Paul Severin
    David Mathews
    Eleanor Lisbon
    Gabriella Mariani
    European Journal of Clinical Pharmacology, 2017, 73 : 175 - 184
  • [32] IN VITRO METABOLIC PATHWAY IDENTIFICATION FOR HERB MEDICINES - THE EFFECTS OF CYTOCHROME P450 ISOZYME CYP1A2, 2B6, 2C19, 2E1 AND 3A4 ON EFFICACY OF GINKGO EXTRACTS AS INHIBITION OF PAF-ACTIVATED PLATELET AGGREGATION USING HUMAN CYROPRESERVED HEPATOCYTES
    Qiu, Dongying
    Mao, Yuchang
    Qiao, Yanyong
    Tan, Jinxin
    Cai, Yingyun
    Hu, Zhuohan
    DRUG METABOLISM REVIEWS, 2007, 39 : 357 - 358
1234